Tongling Jieya Biotechnology, a leading Chinese producer of wet wipes and hygiene products, has formally approved the establishment of a state-of-the-art factory in Egypt. The project, which involves a total investment of RMB 467.1 million ($68.5 million), is designed to serve as the company's primary production and export hub for global markets outside of East Asia and the United States.

The facility will be constructed on a 160,000 square meter plot, valued at $8.5 million, within the China-Egypt TEDA Suez Economic and Trade Cooperation Zone. This location was selected for its proximity to the Suez Canal, providing Tongling Jieya with direct access to shipping lanes connecting three continents.

The company stated that Egypt’s diverse portfolio of Free Trade Agreements (FTAs) with Europe, Africa, and the Americas was the primary driver for the investment.

“Jieya’s overseas revenue doubled to CNY520 million in 2025, fueling our international footprint,” stated company executives. Total 2025 revenue hit CNY770 million—a 41% year-over-year surge—bolstered by wet tissue leadership since 1999. The Egypt hub leverages free-trade advantages for seamless exports to Europe and the US, enhancing supply chain resilience amid rising global hygiene needs"

The "Egypt Biotech Project" is a high-capacity manufacturing complex which will include a total of 14 high-speed production lines. Once the two-year construction phase is complete, the facility is projected to reach staggering annual production milestones:

• 10 billion wet wipes: Spanning baby care, medical, and household disinfection categories.
• 2 billion baby diapers: Utilizing high-speed automated lines to compete in the regional premium market.
• 100,000 tonnes of nonwoven fabrics: The plant will feature proprietary water-jet (spunlace) and hot-air technology lines, allowing the company to produce its own raw materials on-site.

By including 14 lines on a single 160,000 square meter site, Tongling Jieya aims to achieve "maximum vertical integration," producing the fabric, the solution (biotech formulations), and the final packaging in one continuous loop.

Economic and Business Impact:

• Revenue Growth: The company estimates that the Egyptian facility will generate approximately $270 million in annual revenue at full capacity.
• Employment: The project is expected to create 1,000 direct jobs for the local Egyptian workforce, including specialized roles in quality control and technical engineering.
• Financial Resilience: Following a record-breaking 2025 where overseas sales doubled to $76 million, Tongling Jieya views this plant as a critical hedge against domestic market fluctuations and rising logistics costs.

Tongling Jieya’s entry is part of a coordinated wave of Chinese investment in the SCZONE. This "cluster" strategy includes a $190 million tire manufacturing plant by Chaoyang Langma and a massive $800 million polyester fiber complex by Xin Feng Ming. Together, these projects are transforming the TEDA-Suez zone into a vertically integrated powerhouse for synthetic fibers and hygienic consumables.